Tempus AI (NASDAQ:TEM) Trading Up 4.1%

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) traded up 4.1% during mid-day trading on Tuesday . The company traded as high as $63.79 and last traded at $63.00. 187,416 shares traded hands during trading, a decline of 85% from the average session volume of 1,221,160 shares. The stock had previously closed at $60.51.

Analysts Set New Price Targets

TEM has been the topic of a number of research reports. William Blair assumed coverage on Tempus AI in a research note on Tuesday, July 9th. They issued an "outperform" rating on the stock. JPMorgan Chase & Co. upped their price target on shares of Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Needham & Company LLC reaffirmed a "buy" rating and issued a $47.00 price objective on shares of Tempus AI in a research note on Wednesday, August 7th. TD Cowen started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $50.00 target price on the stock. Finally, Piper Sandler assumed coverage on shares of Tempus AI in a research report on Monday, August 12th. They issued a "neutral" rating and a $40.00 price target on the stock. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $45.56.

Tempus AI Trading Up 13.2 %

The business has a 50-day moving average of $41.13.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, sell-side analysts expect that Tempus AI, Inc. will post -6.51 earnings per share for the current year.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently made changes to their positions in TEM. Sandia Investment Management LP acquired a new stake in shares of Tempus AI in the 2nd quarter valued at $136,000. Northwestern University acquired a new stake in shares of Tempus AI in the second quarter worth about $491,000. Squarepoint Ops LLC bought a new stake in shares of Tempus AI during the 2nd quarter worth about $633,000. WINTON GROUP Ltd acquired a new position in shares of Tempus AI during the 2nd quarter valued at about $634,000. Finally, Scientech Research LLC bought a new position in shares of Tempus AI in the 2nd quarter valued at approximately $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.